# How Technology Is Reshaping Human Reproduction

IVF technology has evolved dramatically since Louise Brown's birth in 1978, the first successful test tube baby. What started as a experimental procedure with modest success rates has become a sophisticated field where innovation compounds rapidly.

Current IVF advances focus on several fronts. Genetic screening now identifies embryos with chromosomal abnormalities before implantation, reducing miscarriage risk and increasing live birth rates. Time-lapse imaging systems monitor embryo development continuously, allowing embryologists to select the most viable candidates without removing them from incubation. Artificial intelligence increasingly analyzes embryo morphology, potentially outperforming human assessment in identifying which eggs will develop into healthy pregnancies.

Emerging technologies push further. Researchers explore lab-grown gametes, creating sperm and eggs from other cell types, which could expand fertility options for people with no viable reproductive cells. Mitochondrial replacement therapy addresses maternally inherited genetic diseases by swapping dysfunctional mitochondria in eggs. Some scientists investigate fully artificial wombs, though regulatory and ethical frameworks remain undeveloped.

The implications reach beyond infertility treatment. These technologies enable genetic selection, sex selection, and potentially more complex trait modification. Accessibility remains unequal. IVF cycles cost $12,000 to $15,000 in the U.S., placing treatment beyond reach for many. Most insurance doesn't cover it.

Ethical questions intensify alongside capability. Gene editing in reproductive cells raises concerns about designer babies and unforeseen genetic consequences. The ability to screen for non-disease traits invites scrutiny about which traits society values. Regulatory approaches vary globally, from permissive in some countries to restrictive elsewhere.

These technologies work. Success rates now hover around 50 percent for women under 35. For people unable to conceive naturally, IV